Tegretol
4 customer reviewsTegretol is a prescription anticonvulsant containing carbamazepine. It is used for people with certain epileptic seizures, trigeminal neuralgia, and selected cases of bipolar disorder. It works by calming overactive nerve signalling mainly through sodium-channel blockade.
What is it?
Tegretol is a brand of Carbamazepine, an anticonvulsant medicine that also has mood-stabilising properties. Doctors most often use it for focal (partial) seizures, generalised tonic-clonic seizures, and for trigeminal neuralgia (sudden, severe facial nerve pain). In psychiatry, it can be used in bipolar disorder when a mood stabiliser is needed.
It is a long-established treatment option, which means many of its benefits, limitations, and interaction risks are well mapped out in day-to-day practice.
Composition
Active ingredient: carbamazepine (in tablet form). Excipients vary by manufacturer and may include fillers, binders, disintegrants, and film-coating agents; check the product leaflet for the exact list for the specific tablet strength.
How to use?
Used for the treatment of partial (focal) seizures and generalised tonic-clonic seizures, and for relief of trigeminal neuralgia and other neuropathic pain where prescribed. It may also be prescribed for certain mood-stabilisation indications under specialist supervision. Use only as directed by a clinician due to interaction and monitoring needs.
How does it work?
- Route: oral (tablets), swallowed with water.
- Adults (epilepsy, typical start): 100–200 mg 1–2 times/day, then increase by 100–200 mg every 3–7 days.
- Adults (usual maintenance, epilepsy): 800–1,200 mg/day in 2–4 divided doses; some patients may require up to 1,600 mg/day as prescribed.
- Trigeminal neuralgia (adults, typical start): 100 mg 2 times/day, then increase by 100–200 mg/day until pain control; usual range 400–800 mg/day in divided doses (max often 1,200 mg/day per prescriber).
- Timing with food: take with or after meals to reduce stomach upset; if multiple daily doses, space evenly (e.g., morning and evening).
- Duration: long-term for seizure control; for neuralgia, continue for the prescribed period and reduce gradually when stopping.
- Do not stop abruptly: dose reductions are typically done gradually over weeks under medical direction.
Indications
Tegretol, containing the active ingredient Carbamazepine, is a medicine used to control certain types of epileptic seizures and to treat nerve pain such as trigeminal neuralgia. It is also used as a mood stabiliser in bipolar disorder for some patients.
Comparison
Tegretol is the brand name; Carbamazepine is the active ingredient. Clinically, the core effect comes from carbamazepine, regardless of whether a prescription is written using the brand name or the generic name.
What changes between products is usually the release pattern (how quickly the medicine is released after swallowing) and the dosing schedule that follows from it. Release characteristics can change how steady your blood level is across the day, which can affect sleepiness, dizziness, and seizure control consistency.
Brand vs generic at a glance
| Item | What it means | Key point |
|---|---|---|
| Tegretol | Brand name | Contains carbamazepine |
| Carbamazepine | Generic name | Same active ingredient |
Contraindications
- Hypersensitivity/allergy to carbamazepine (or related compounds)
- Atrioventricular (AV) block or significant cardiac conduction disease
- Acute porphyrias
- Concomitant use of monoamine oxidase inhibitors (MAOIs), or recent MAOI use without adequate washout
Not recommended for
This medication is NOT for you if any of the following apply, unless your prescriber has made a specific, documented decision otherwise:
- Allergy/hypersensitivity to Carbamazepine (or related compounds)
- Atrioventricular (AV) block or significant cardiac conduction disease
- Acute porphyrias
- Current use of monoamine oxidase inhibitors (MAOIs), or recent MAOI use with inadequate washout
Breastfeeding and pregnancy are not automatic “no” situations, yet they require careful specialist-led risk management for the individual case.
Side effects
Side effects are most common when starting or after a dose increase. Many patients describe the first 1–2 weeks as the “wobbly phase,” then things often ease once the dose is stable.
Commonly reported effects include:
- Dizziness or light-headedness
- Drowsiness or fatigue
- Unsteadiness/poor coordination
- Nausea, stomach upset
- Blurred or double vision
- Mild skin rash
Serious side effects are less common, but they are clinically important:
- Severe skin reactions (a rapidly spreading rash, blistering, mouth ulcers)
- Low sodium (confusion, severe headache, worsening seizures)
- Blood count suppression (unusual infections, fever, easy bruising)
- Liver injury (dark urine, yellowing of skin/eyes, strong persistent nausea)
This can affect driving. Some people felt “drunk” on day one. [2]
Common mistakes
People usually get into trouble with Tegretol in predictable ways. These patterns show up again and again in neurology clinics.
- Stopping suddenly once symptoms improve. Seizures can rebound, and trigeminal neuralgia pain can flare hard. Tapering plans exist for a reason.
- Doubling a dose after missing one. That can cause pronounced dizziness, double vision, vomiting, and unsteadiness.
- Starting new medicines without an interaction check. Antibiotics, antifungals, mood medicines, and even some supplements can shift carbamazepine levels.
- Ignoring an early rash. A mild rash can stay mild, or it can escalate fast; early medical triage is safer than waiting it out.
- Using alcohol to “counter” anxiety or insomnia. Sedation can stack, coordination worsens, and sleep quality often gets worse after the initial knock-out.
Doctor opinions
In clinical practice, prescribers often choose Tegretol when the diagnosis fits its strengths: focal seizures, classic trigeminal neuralgia, or bipolar disorder when another mood stabiliser is not suitable or not enough. For trigeminal neuralgia, the response can be striking when it works well, with fewer electric-shock pain attacks within days of reaching a working dose, though dose titration still needs patience.
Neurologists also see the “enzyme induction” issue play out: weeks after starting, a patient can feel less sleepy yet also slightly less controlled, because the body is clearing the drug faster. This is one reason follow-up and dose refinement matter more with carbamazepine than with many newer antiseizure medicines.
Psychiatrists tend to be selective with carbamazepine in bipolar disorder because interactions can be extensive, and blood monitoring may be needed in some patients. The trade-off is that, in the right patient, it can smooth manic symptoms without the emotional flattening some people report on other options.
Frequently asked questions
For seizure control, some benefit can appear after the dose begins to rise, but stable control is usually judged over weeks, since titration is gradual and blood levels settle over time. For trigeminal neuralgia, pain relief may appear earlier once a therapeutic dose is reached. Clinical guidance used across regulated settings emphasises dose titration to reduce early dizziness and rash risk rather than rushing to a target dose.
If you remember relatively soon, take your usual dose. If it is close to the next scheduled dose, skip the missed one and return to your normal schedule, since double dosing can spike side effects. Patient-safety materials across health systems consistently prioritise avoiding harm from accidental extra doses with high-interaction medicines. If missed doses happen often, your prescriber may adjust timing to fit your routine.
Alcohol can intensify drowsiness, dizziness, and poor coordination, especially early in treatment or after dose increases. It can also worsen sleep architecture, which can make seizure thresholds less stable in some people. The consistent theme in health education around antiseizure medicines is avoiding additive central nervous system depression with alcohol when a medicine already causes sedation. If you do drink, clinicians often advise keeping it minimal and consistent, not episodic heavy intake.
Yes. Carbamazepine can reduce the effectiveness of many hormonal contraceptives by speeding up hormone metabolism, which can lead to breakthrough bleeding and unintended pregnancy. This is a pharmacokinetic interaction, so it can persist as long as Tegretol is used. Reduced contraceptive reliability is a key counselling point in prescribing information for carbamazepine. Many patients switch to a non-hormonal method or use a backup method.
Doctors may order baseline and follow-up blood tests that can include full blood count, liver function, and sodium, since carbamazepine can affect each of these. Some patients also have carbamazepine blood levels checked when control is poor, side effects are strong, or interacting drugs are added. In clinical practice, monitoring frequency is individualised and tighter during initiation and dose changes. If you have symptoms like fever, mouth ulcers, unusual bruising, or jaundice, testing becomes more urgent.
Yes, carbamazepine is used as a mood stabiliser in bipolar disorder for selected patients, often for manic symptoms and relapse prevention. Psychiatrists choose it carefully because interactions can complicate treatment plans, and sedation can be limiting early on. Carbamazepine remains an option when first-line mood stabilisers are not suitable or tolerated. Dose titration and interaction review are central to success.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Tegretol — Comparison with alternatives
Tegretol Current Best price
Cytomel
Cosopt
Vesicare Best rated
Travatan
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Carbamazepine: Summary of Product Characteristics and safety information. ↑
- World Health Organization (WHO) (2026). Epilepsy: key facts and treatment principles. ↑
- World Health Organization (WHO) (2026). Breastfeeding and maternal medication: general principles for risk–benefit decisions. ↑
- National Institute for Health and Care Excellence (NICE) (2025). Epilepsies in children, young people and adults: diagnosis and management. ↑
- MOHAP (Ministry of Health and Prevention) (2026). Medication safety guidance for high-interaction prescription medicines. ↑